Roche Adds AI-Powered Solution to its Digital Pathology Platform
Qritive has partnered with Roche to integrate its AI-powered cancer diagnostic tools with the Roche navify Digital Pathology platform.
Read MorePosted by Andy Lundin | Sep 13, 2024 | Digital Pathology |
Qritive has partnered with Roche to integrate its AI-powered cancer diagnostic tools with the Roche navify Digital Pathology platform.
Read MorePosted by Chris Wolski | Sep 10, 2024 | Prostate |
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Read MorePosted by Andy Lundin | Sep 5, 2024 | Breast, Digital Pathology |
Ibex has introduced advancements to its AI-powered platform, enhancing breast cancer diagnostics, improving algorithm accuracy, and more.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Cancer, Histology |
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read MorePosted by Andy Lundin | Aug 30, 2024 | Prostate |
GRAIL’s Galleri multi-cancer early detection test demonstrates strong performance in preferentially identifying aggressive prostate cancers.
Read More